Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Buffered Lidocaine Syringes at Brooke Army Medical Center, JBSA Ft. Sam Houston, TX

Active
W81K00-26-Q-A001Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Medical Readiness Contracting Office – West at Joint Base San Antonio Ft. Sam Houston, Texas, is seeking potential sources through a Sources Sought notice to supply approximately 6,000 Buffered Lidocaine Syringes (1% buffered with 8.4% sodium bicarbonate, 10ml per syringe) annually for Brooke Army Medical Center. The contract will include a base period of twelve months starting October 1, 2026, with up to four additional twelve-month option periods, extending the total possible contract duration to September 30, 2031. This notice aims to gather market information to assist in developing the acquisition strategy and may lead to a small business set-aside or a full and open competition depending on the responses received. Interested vendors must submit tailored capability statements addressing the specific requirements and questions posed, including details about their firm, small business status, and opinion on the applicable NAICS code 339112 for surgical and medical instrument manufacturing. Responses are to be emailed by May 14, 2026, to the designated Contract Specialist and Contracting Officer, with no phone inquiries or general capability statements accepted. This sources sought is for informational purposes only and does not constitute a solicitation or commitment to award a contract, nor are funds available for response preparation. All submissions are voluntary, will not be returned, and must not include classified information.

General Info

Seeking suppliers for 6,000 buffered lidocaine syringes annually, contract starts October 2026.

Agency

Department Of Defense → W40M MRC0 West

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

DWG, TX, 78234, USA

Set-Aside

SBA

Documents

(2)

Solicitation+Amendment+W81K0026QA1840001+SF+30.pdf

PDF

Solicitation+-+W81K0026QA184+Professional+Appearance.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseCombined Synopsis
Amendment 0

Contract was updated

Posted

Combined Synopsis

Amendment 2

Contract was updated

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → W40M MRC0 West
Contacts2 people available
OfficeJBSA FT SAM HOUSTON, TX, 78234-4504, USA
Organization / Agency
Department Of Defense → W40M MRC0 West
Office AddressJBSA FT SAM HOUSTON, TX, 78234-4504, USA
Contacts
Patrick Thielemann
Christopher Gregory

Full Description

Show more

Please complete the SF1449: Blocks 17 (to include the CAGE code and the Unique Entity ID Number) and 30 A - C.



Please provide a statement that the offeror will hold its quote firm for at least 90 days from the due date for receipt of quotes, subject to any changes that may occur as a result of discussions (if applicable).



Please complete the provisions, as listed in the solicitation. Alternately, complete all provisions in System for Award Management (SAM) and provide confirmation of completion and accuracy with offer. Potential contractors must be registered in SAM to be eligible for award. The SAM website is http://www.sam.gov.



Quotes are due by no later than (NLT) 11:00 AM/CT on 24 June 2026. Quotes shall be submitted via email to patrick.a.thielemann.civ@health.mil and christopher.a.gregory11.civ@health.mil. Quotes received after the deadline will be considered untimely and will not be eligible for award. Questions are by NLT 11:00 AM/CT on 15 June 2026. All questions must be
submitted in writing to patrick.a.thielemann.civ@health.mil and christopher.a.gregory11.civ@health.mil. Electronic submissions with files larger than 20MB will need to be submitted in separate emails. All emails, regardless of the size, need to be received by the Government server, by the stated date and time. It is the offeror's responsibility to ensure the Government receives the entire quote.



Factor 1. Compliance with specification: The contractor must provide proof of compliance
federal regulations, as outlined by the FDA, and state regulations in the production and/or
distribution of the required producsts.



Factor 2. Price: Offeror shall complete the pricing for each of the contract line items (CLINS)
under the Continuation of Supplies or Services and Prices/Costs or provide a separate
document with the pricing for each CLIN.

Similar Contracts

NAICS: 325412
New
Federal
6505--Dutasteride CapsulesThe Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0029) for the procurement of Dutasteride Capsules to serve multiple federal agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted contract aims to secure a reliable supply source for Dutasteride 0.5MG capsules in both 30-count and 90-count bottles, with annual estimated usage of approximately 3,912 and 25,502 bottles respectively. The contract will be awarded to a single responsible offeror who can provide an uninterrupted supply and will have a one-year base period followed by four one-year option periods. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must supply the drug under the exact name on the label, with a unique National Drug Code (NDC) exclusive to the offeror. The contractor’s label must be the sole label on the product, with VA labels designed to adhere securely on top without obscuring important information such as barcodes, expiration dates, and lot numbers. Packaging requirements include safety caps that meet specific design criteria with a minimum bottle volume of 120cc and cylindrical shape to accommodate appropriate labeling sizes. The solicitation will be released in a commercial item format in accordance with FAR Part 12 around June 22, 2026, with proposals due by July 7, 2026. Interested parties should monitor SAM.gov for updates and submit offers electronically; efforts to obtain paper copies will not be accommodated. The contract specialist and primary point of contact for this procurement is Richard Mahario.
Nac Pharmaceuticals (36E797)

POSTED

1 day ago

DEADLINE

in 21 days
View Details